| Application no. and date | 13168404.5 (espacenet) (Federated) (European Patent Register), 20090210 | | Patent/reg. no. and date | DK/EP 2650012, 20150325 | | Publication date | 20131016 | | Priority no. and date | US 27741 P, 20080211, EP 08250703, 20080229, US 147956 P, 20090128 | | EP pub. no. and date |
EP 2650012 20131016 | | Effective date | | | Applicant/owner | Ferring B.V., Polaris Avenue 144
2132 JX Hoofddorp, NL | | Applicant ref. no. | 158863 | | Inventor | Persson, Bo-Eric, Ch du Canard 37
CH-1162 St-Prex, CH | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/09 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | Behandling af prostatacancer i metastasestadium med degarelix. | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
